Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?

Thorax

Volumn 69, Issue 3, 2014, Pages 254-260

  Ooi, Chee Y ^a,b,c   Dupuis, Annie ^b,d   Ellis, Lynda ^b   Jarvi, Keith ^e   Martin, Sheelagh ^b   Ray, Peter N ^a,b,d   Steele, Leslie ^b,d   Kortan, Paul ^f   Gonska, Tanja ^a,b   Dorfman, Ruslan ^a   Solomon, Melinda ^a,b   Zielenski, Julian ^a   Corey, Mary ^b,d   Tullis, Elizabeth ^f,g   Durie, Peter ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c SYDNEY CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF TORONTO   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE;

ADULT; ARTICLE; AZOOSPERMIA; CHRONIC PANCREATITIS; CHRONIC SINOPULMONARY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENOTYPING TECHNIQUE; HUMAN; INTERMETHOD COMPARISON; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NASAL POTENTIAL DIFFERENCE; PRIORITY JOURNAL; RESPIRATORY TRACT PARAMETERS; SWEAT TEST;

BRONCHIECTASIS; CYSTIC FIBROSIS; PAEDIATRIC LUNG DISAESE;

ADULT; ALLELES; BIOLOGICAL MARKERS; COHORT STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; NASAL MUCOSA; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SODIUM CHLORIDE; SWEAT;

EID: 84893972760     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203832     Document Type: Article

References (35)

1. Rommens JM, Iannuzzi MC, Kerem B, et al Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245:1059-65. (Pubitemid 19231813)
2. Cohn JA, Friedman KJ, Noone P.G., et al Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998; 339:653-8. (Pubitemid 28402089)
3. Ooi CY, Dorfman R, Cipolli M., et al Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology 2011; 140:153-61.
4. Bishop MD, Freedman SD, Zielenski J, et al The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Human Genetics 2005; 118:372-81. (Pubitemid 43091209)
5. Girodon E, Cazeneuve C, Lebargy F., et al CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet 1997; 5:149-55. (Pubitemid 27356702)
6. Bombieri C, Benetazzo M, Saccomani A., et al Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease. Hum Genet 1998; 103:718-22. (Pubitemid 29020770)
7. Jarvi K, Zielenski J, Wilschanski M., et al Cystic fibrosis transmembrane regulator and obstructive azoospermia. Lancet 1995; 345:1578.
8. Wilschanski M, Dupuis A, Ellis L., et al Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials. Am J Resp Crit Care Med 2006; 174:787-94. (Pubitemid 44511660)
9. Gonska T, Choi P, Stephenson A., et al Role of cystic fibrosis transmembrane regulator (CFTR) in patients with chronic sinopulmonary disease. Chest 2012; 142:996-1004.
10. Farrell PM, Rosenstein BJ, White T.B., et al Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation Consensus Report. J Pediatr 2008; 153:S4-14.
11. De Boeck K., Wilschanski M, Castellani C., et al Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006; 61:627-35. (Pubitemid 44035145)
12. Di Sant'Agnese PA, Darling RC, Perera GA, et al. Sweat electrolyte disturbances associated with childhood pancreatic disease. Am J Med 1953; 15:777-83.
13. Gibson LE, Cooke RE A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959; 23:545-9.
14. Shwachman HMA. Pilocarpineiontophoresis sweat testing results of seven years' experience. In: Rossi E, Stoll E. eds. Modern Problems in Pediatrics. Basel/NY: S Karger AG, 1967:158-82.
15. Mishra A, Greaves R, Massie J. The limitations of sweat electrolyte reference intervals for the diagnosis of cystic fibrosis: a systematic review. Clin Biochem Rev 2007; 28:60-76.
16. Bombieri C, Claustres M, De Boeck K, et al Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros 2011; 10(Suppl. 2):S86-102.
17. John Hopkins University, Baltimore. Clinical and Functional Translation of CFTR. http://www.cftr2.com
18. Ooi CY, Dupuis A, Ellis L., et al Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language? Thorax 2012; 67:618-24.
19. Knowles MR, Paradiso AM, Boucher RC In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transferin cystic fibrosis. Hum Gene Ther 1995; 6:445-55.
20. Zielenski J, Aznarez I, Onay T., et al CFTR mutation detection by multiplex heteroduplex (mHET) analysis on MDE gel. Methods Mol Med 2002; 70:3-19.
21. Ferec C, Casals T, Chuzhanova N., et al Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms. Eur J Hum Genet 2006; 14:567-76.
22. Audrezet MP, Chen JM, Raguenes O, et al Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum Mutat 2004; 23:343-57.
23. Landis JR, Koch GG The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-74. (Pubitemid 8054849)
24. Wang SS, O'Leary LA, Fitzsimmons SC, et al The impact of early cystic fibrosis diagnosis on pulmonary function in children. J Pediatr 2002; 141:80.
25. Hankinson JL, Odencrantz JR, Fedan KB Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179-87. (Pubitemid 29036522)
26. Mishra A, Greaves R, Smith K., et al Diagnosis of cystic fibrosis by sweat testing: age-specific reference intervals. J Pediatr 2008; 153:758-63.
27. Hirtz S, Gonska T, Seydewitz H.H., et al CFTR Clchannel function in native human colon correlates with the genotype and phenotype in cystic fibrosis. Gastroenterology 2004; 127:1085-95. (Pubitemid 39345878)
28. Carlin RW, Quesnell RR, Zheng L, et al Functional and molecular evidence for Na (+)-HCO cotransporter in porcine vas deferens epithelia. Am J Physiol Cell Physiol 2002; 283:C1033-44.
29. Quinton P, Molyneux L, Ip W., et al β-Adrenergic sweat secretion as a diagnostic test for cystic fibrosis. Am J Respir Crit Care Med 2012; 186:732-9.
30. Ramalho AS, Lewandowska MA, Farinha C.M., et al Deletion of CFTR translation start site reveals functional isoforms of the protein in CF patients. Cell Physiol Biochem 2009; 24:335-46.
31. Raynal C, Baux D, Theze C., et al A classification model relative to splicing for variants of unknown clinical significance: application to the CFTR gene. Hum Mutat 2013; 34:774-84.
32. Dorfman R, Nalpathamkalam T, Taylor C., et al Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene? Clin Genet 2010; 77:464-73.
33. Gilljam M, Moltyaner Y, Downey G.P., et al Airway inflammation and infection in congenital bilateral absence of the vas deferens. Am J Respir Crit Care Med 2004; 169:174-9. (Pubitemid 38114531)
34. Durno C, Corey M, Zielenski J., et al Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002; 123:1857-64. (Pubitemid 35408310)
35. Nick JA, Chacon CS, Brayshaw S.J., et al Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis. Am J Respir Crit Care Med 2010; 182:614-26.